Announcement

Collapse
No announcement yet.

Sci Rep . Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Sci Rep . Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein


    Sci Rep


    . 2022 Nov 22;12(1):20120.
    doi: 10.1038/s41598-022-24730-4.
    Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein


    Ryota Otsubo # 1 , Takeharu Minamitani # 1 2 , Kouji Kobiyama 3 4 , Junso Fujita 5 6 , Toshihiro Ito 7 8 , Shiori Ueno 9 , Itsuki Anzai 10 , Hiroki Tanino 6 , Hiroshi Aoyama 6 , Yoshiharu Matsuura 11 12 , Keiichi Namba 5 13 14 , Ken-Ichi Imadome 15 , Ken J Ishii 3 4 , Kouhei Tsumoto 16 17 18 , Wataru Kamitani 9 , Teruhito Yasui 19



    Affiliations

    Abstract

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). Variants of concern (VOCs) such as Delta and Omicron have developed, which continue to spread the pandemic. It has been reported that these VOCs reduce vaccine efficacy and evade many neutralizing monoclonal antibodies (mAbs) that target the receptor binding domain (RBD) of the glycosylated spike (S) protein, which consists of the S1 and S2 subunits. Therefore, identification of optimal target regions is required to obtain neutralizing antibodies that can counter VOCs. Such regions have not been identified to date. We obtained 2 mAbs, NIBIC-71 and 7G7, using peripheral blood mononuclear cells derived from volunteers who recovered from COVID-19. Both mAbs had neutralizing activity against wild-type SARS-CoV-2 and Delta, but not Omicron. NIBIC-71 binds to the RBD, whereas 7G7 recognizes the N-terminal domain of the S1. In particular, 7G7 inhibited S1/S2 cleavage but not the interaction between the S protein and angiotensin-converting enzyme 2; it suppressed viral entry. Thus, the efficacy of a neutralizing mAb targeting inhibition of S1/2 cleavage was demonstrated. These results suggest that neutralizing mAbs targeting blockade of S1/S2 cleavage are likely to be cross-reactive against various VOCs.


Working...
X